KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Debt (2016 - 2025)

AbbVie (ABBV) has disclosed Non-Current Debt for 14 consecutive years, with $58.9 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 2.32% to $58.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.9 billion through Dec 2025, down 2.32% year-over-year, with the annual reading at $58.9 billion for FY2025, 2.32% down from the prior year.
  • Non-Current Debt for Q4 2025 was $58.9 billion at AbbVie, down from $63.0 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $74.2 billion in Q2 2021, with the low at $52.2 billion in Q4 2023.
  • Average Non-Current Debt over 5 years is $62.2 billion, with a median of $60.7 billion recorded in 2022.
  • The sharpest move saw Non-Current Debt increased 17.22% in 2021, then dropped 18.43% in 2022.
  • Over 5 years, Non-Current Debt stood at $64.2 billion in 2021, then dropped by 7.87% to $59.1 billion in 2022, then dropped by 11.74% to $52.2 billion in 2023, then rose by 15.61% to $60.3 billion in 2024, then decreased by 2.32% to $58.9 billion in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $58.9 billion, $63.0 billion, and $63.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.